Inventor · disambiguated record
Weifang Shan
Also filed as: SHAN WEIFANG
28 granted patents·2 pending applications·123 citations·filing 2001–2022
95Inventor score
Top patents by PatentIndex Score
30 records- 0196US9643972B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2015·Granted May 9, 2017·15 cites·47 claims
- 0296US9598422B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2015·Granted Mar 21, 2017·21 cites·34 claims
- 0394US9790169B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Oct 17, 2017·19 cites·27 claims
- 0493US10106546B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2017·Granted Oct 23, 2018·6 cites·66 claims
- 0590US7001911B2Fused cyclic modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Feb 21, 2006·31 cites·21 claims
- 0689US10533014B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2018·Granted Jan 14, 2020·3 cites·20 claims
- 0786US10633342B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 28, 2020·2 cites·17 claims
- 0885US11066383B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 20, 2021·3 cites·15 claims
- 0983US11548870B2Compounds useful as inhibitors of helios proteinBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jan 10, 2023·1 cites·12 claims
- 1083US10696648B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 30, 2020·3 cites·20 claims
- 1183US10399933B2Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancerBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 3, 2019·3 cites·13 claims
- 1282US10399932B2Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancerBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 3, 2019·3 cites·13 claims
- 1381US9133139B2Fluoroalkyl-1,4-benzodiazepinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Sep 15, 2015·2 cites·10 claims
- 1478US7432267B2Fused cyclic modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Oct 7, 2008·2 cites·14 claims
- 1577US11649212B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2018·Granted May 16, 2023·1 cites·4 claims
- 1677US10689331B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 23, 2020·2 cites·17 claims
- 1776US12145927B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 19, 2024·1 cites·11 claims
- 1876US9624188B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Apr 18, 2017·3 cites·11 claims
- 1975US10167254B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 1, 2019·1 cites·43 claims
- 2074US11337970B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 24, 2022·1 cites·5 claims
- 2159US2025346574A1Pyridinyl substituted oxoisoindoline compounds for the treatment of cancerBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2256US10206893B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2017·Granted Feb 19, 2019·0 cites·23 claims
- 2353US9249157B2Tricyclic heterocycle compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Feb 2, 2016·0 cites·8 claims
- 2450US11066392B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 20, 2021·0 cites·24 claims
- 2549US12059420B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Aug 13, 2024·0 cites·6 claims
- 2649US10323004B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 18, 2019·0 cites·18 claims
- 2747US8466171B2Fused heterocyclic compounds useful as modulators of nuclear hormone receptor functionSHAN WEIFANG·Filed 2008·Granted Jun 18, 2013·0 cites·3 claims
- 2847US7468439B2Alkylene bridged sultam compounds useful as modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Dec 23, 2008·0 cites·12 claims
- 2942US8067582B2Fused heterocyclic compounds useful as modulators of nuclear hormone receptor functionNORRIS DEREK J·Filed 2008·Granted Nov 29, 2011·0 cites·9 claims
- 3040US2003114420A1Fused cyclic modulators of nuclear hormone receptor functionFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Weifang Shan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →